# A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants

> **NCT05662215** · PHASE1 · TERMINATED · sponsor: **Cytokinetics** · enrollment: 57 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** CK-3828136
- **DRUG:** Placebo for CK-3828136

## Key facts

- **NCT ID:** NCT05662215
- **Lead sponsor:** Cytokinetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-12-06
- **Primary completion:** 2023-08-08
- **Final completion:** 2023-08-08
- **Target enrollment:** 57 (ACTUAL)
- **Why stopped:** Terminated early per sponsor decision.
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05662215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05662215, "A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05662215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*